PATENT CLAIM ANALYSIS

Application Number: 16043721
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["544", "362000"]

Abstract:
Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m 2 /g; and crystals of aripiprazole lauroxil produced by such processes.

Claim (Index 28):
The process of  claim 21 , wherein in step (a), the first solvent is isopropyl acetate.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.25
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14833638', '14828229', '15767966', '11281489', '14604334']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7262339662340237
- 35 USC 102 Novelty (BERT): 0.573774574718423
- Combined Prediction Score: 0.7109880270824637
- Mean Citation Score: 239.44261
- Max Citation Score: 487.66064000000006
- Similarity Product: 351.05969201974875

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test